Skip to search formSkip to main contentSkip to account menu

Clarithromycin

Known as: CLARITH, Clarithromycina, Clarithromycin [Chemical/Ingredient] 
A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis… 
National Institutes of Health

Related topics

Related topics

42 relations

Narrower (2)

14-hydroxyclarithromycinBiaxin
24 HR Clarithromycin 500 MG Extended Release Oral Tablet6-O-methylerythromycin AAcute intermittent porphyriaAstemizole

Broader (3)

Anti-Bacterial AgentsCytochrome P-450 CYP3A InhibitorsMacrolide Antibiotics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Growth performance and fatty acid profiles of intramuscular and subcutaneous fat from Limousin and Charolais heifers fed extruded linseed.
Review
2005
Review
2005
Detection of reactive oxygen species in the skin of live mice and rats exposed to UVA light: a research review on chemiluminescence and trials for UVA protection
The harmful effects of ultraviolet (UV) exposure on the skin are associated with the generation of reactive oxygen species (ROS… 
Highly Cited
2004
Highly Cited
2004
Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma
A randomised double-blind placebo-controlled study was designed to evaluate the effects of a semisynthetic macrolide antibiotic… 
Highly Cited
2003
Highly Cited
2003
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection
Aim : To test the efficacy of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy for the second‐line… 
Highly Cited
2003
Highly Cited
2003
Milk conjugated linoleic acid response to fish oil supplementation of diets differing in fatty acid profiles.
The objective of this experiment was to examine the effect of feeding fish oil (FO) along with fat sources that varied in their… 
Highly Cited
2002
Highly Cited
2002
Impact of Furazolidone‐Based Quadruple Therapy for Eradication of Helicobacter pylori after Previous Treatment Failures
Background. One week of quadruple therapy including metronidazole is recommended for Helicobacter pylori treatment failures after… 
Highly Cited
2000
Highly Cited
2000
Third line treatment for Helicobacter pylori: a prospective, culture‐guided study in peptic ulcer patients
A third line treatment is needed in roughly 5% of patients infected with Helicobacter pylori. Few data have been reported on… 
Highly Cited
1999
Highly Cited
1999
Quadruple Therapy Is Effective for Eradicating Helicobacter pylori After Failure of Triple Proton‐Pump Inhibitor–Based Therapy: A Detailed, Prospective Analysis of 21 Consecutive Cases
Background. Data regarding the effectiveness of second‐line treatment of Helicobacter pylori infection are limited, especially if… 
Highly Cited
1995
Highly Cited
1995
Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin
The intrapulmonary pharmacokinetics of orally administered clarithromycin (500 mg every 12 h for five doses) or erythromycin (250… 
Highly Cited
1991
Highly Cited
1991
The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans.
The diffusion of clarithromycin and roxithromycin into respiratory tract tissues was studied in 174 adult patients undergoing… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)